Related Experiment Video
Updated: Sep 11, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Spontaneous Resolution of Miliary Pulmonary Nodules Following Intravesical Bacillus Calmette-Guérin (BCG) Therapy: A
Ahmed R Fadel1, Irem G Yaman2, Sebastián M Urruela3
1Respiratory Medicine, Dartford and Gravesham NHS Trust, Dartford, GBR.
Intravesical Bacillus Calmette-Guérin (BCG) immunotherapy is a well-established treatment for non-muscle-invasive bladder cancer. Although it is typically associated with local irritative symptoms, rare systemic and pulmonary complications can occur, including hypersensitivity pneumonitis and miliary tuberculosis. We report the case of a 70-year-old man who developed diffuse miliary pulmonary micronodules and ground-glass opacities after his 12th BCG instillation. Despite imaging findings suggestive of disseminated infection, the patient remained clinically stable, without fever, hypoxia, or systemic deterioration. Bronchoalveolar lavage cultures were negative for Mycobacterium bovis. A shared decision was made to withhold antimycobacterial therapy and monitor closely. Follow-up imaging revealed spontaneous improvement without treatment. This case underscores that observation may be appropriate in selected stable patients without systemic signs of infection. Careful clinical assessment and individualized management are essential to avoid unnecessary therapy and ensure patient safety.
Intravesical Bacillus Calmette-Guérin (BCG) immunotherapy is a well-established treatment for non-muscle-invasive bladder cancer. Although it is typically associated with local irritative symptoms, rare systemic and pulmonary complications can occur, including hypersensitivity pneumonitis and miliary tuberculosis. We report the case of a 70-year-old man who developed diffuse miliary pulmonary micronodules and ground-glass opacities after his 12th BCG instillation. Despite imaging findings suggestive of disseminated infection, the patient remained clinically stable, without fever, hypoxia, or systemic deterioration. Bronchoalveolar lavage cultures were negative for Mycobacterium bovis. A shared decision was made to withhold antimycobacterial therapy and monitor closely. Follow-up imaging revealed spontaneous improvement without treatment. This case underscores that observation may be appropriate in selected stable patients without systemic signs of infection. Careful clinical assessment and individualized management are essential to avoid unnecessary therapy and ensure patient safety.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pneumothorax-II
Clinical Manifestations:
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: